Vi vil gerne bruge cookies til statistik og annoncer, også fra vores partnere. Du kan altid ændre dit valg.
Jiangxi Rimag Group Co · RD9
Fra 1 stk.
60.000 brugere er allerede i gang
Markedsdata leveret af TwelveData og Morningstar
INVESTER I JIANGXI RIMAG GROUP CO MED ENDAVU: Køb Jiangxi Rimag Group Co ($RD9) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jiangxi Rimag Group Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.
Jiangxi Rimag Group Co., Ltd. is a healthcare services company specializing in medical imaging in China. The group focuses on the full medical imaging value chain, combining clinical service delivery, equipment solutions, and digital platforms. Its core activities include investing in and operating medical imaging centers that provide diagnostic services such as MRI, CT, PET, ultrasound, X-ray, and related procedures to hospitals, health management organizations, and individual patients. In parallel, the company offers imaging solution services that support medical institutions with equipment selection, configuration, software solutions, and operational management to enhance imaging capabilities. Through its Rimag Cloud and broader digital-intelligent services, Jiangxi Rimag Group delivers cloud-based storage, remote diagnosis and consultation, AI-assisted imaging, data processing, and refined operation management tools for imaging centers. Incorporated in 2014 and headquartered in Beijing, China, the company plays a specialized role in the healthcare market by enabling hospitals and clinics to access advanced imaging capacity, technology, and expertise without fully internalizing the associated infrastructure and management costs.